Daewon Pharm (003220) - Total Liabilities

Latest as of September 2025: ₩342.50 Billion KRW ≈ $232.11 Million USD

Based on the latest financial reports, Daewon Pharm (003220) has total liabilities worth ₩342.50 Billion KRW (≈ $232.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003220 cash flow metrics to assess how effectively this company generates cash.

Daewon Pharm - Total Liabilities Trend (2011–2024)

This chart illustrates how Daewon Pharm's total liabilities have evolved over time, based on quarterly financial data. Check 003220 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Daewon Pharm Competitors by Total Liabilities

The table below lists competitors of Daewon Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Orion Minerals Ltd AU:ORN	Australia	AU$59.95 Million
Antony Waste Handling Cell Limited NSE:AWHCL	India	Rs8.38 Billion
Groupe Sfpi PA:SFPI	France	€317.26 Million
Surya Fajar Capital Tbk PT JK:SFAN	Indonesia	Rp70.66 Billion
Habco Trans Maritima JK:HATM	Indonesia	Rp272.19 Billion
China ZhengTong Auto Services Holdings Limited F:ZA0	Germany	€25.47 Billion
Paragon Globe Bhd KLSE:3611	Malaysia	RM384.82 Million
BioInvent International AB ST:BINV	Sweden	Skr105.93 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Daewon Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003220 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.56	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daewon Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daewon Pharm (2011–2024)

The table below shows the annual total liabilities of Daewon Pharm from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩298.81 Billion ≈ $202.50 Million	+22.60%
2023-12-31	₩243.73 Billion ≈ $165.17 Million	+19.02%
2022-12-31	₩204.78 Billion ≈ $138.78 Million	-3.03%
2021-12-31	₩211.18 Billion ≈ $143.11 Million	+72.47%
2020-12-31	₩122.44 Billion ≈ $82.98 Million	-0.71%
2019-12-31	₩123.32 Billion ≈ $83.57 Million	+33.69%
2018-12-31	₩92.24 Billion ≈ $62.51 Million	+56.15%
2017-12-31	₩59.07 Billion ≈ $40.03 Million	+12.16%
2016-12-31	₩52.67 Billion ≈ $35.69 Million	+14.28%
2015-12-31	₩46.09 Billion ≈ $31.23 Million	-0.04%
2014-12-31	₩46.11 Billion ≈ $31.25 Million	+24.99%
2013-12-31	₩36.89 Billion ≈ $25.00 Million	+7.86%
2012-12-31	₩34.20 Billion ≈ $23.18 Million	-6.23%
2011-12-31	₩36.47 Billion ≈ $24.72 Million	--

About Daewon Pharm

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$155.71 Million

₩229.77 Billion KRW

Market Cap Rank

#17502 Global

#819 in Korea

Share Price

₩10720.00

Change (1 day)

-0.83%

52-Week Range

₩10030.00 - ₩14020.00

All Time High

₩23535.34